Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma - PubMed (original) (raw)
Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma
D Bartsch et al. Cancer Lett. 1996.
Abstract
Amplification of the c-myc oncogene occurs in a variety of solid tumors, including pancreatic adenocarcinomas. The MXI1 gene, located at 10q24-q25, may serve to negatively regulate c-myc oncogene activity, and potentially has tumor suppressor function. As such, altered MXI1 function might contribute to tumorigenesis. We examined 40 primary human pancreatic adenocarcinomas for MXI1 mutations. Single-strand conformation variant analysis and direct sequencing of the variants revealed a MXI1 polymorphism in 1 of 40 tumors. No MXI1 mutations were identified. Southern blot analyses did not reveal any gross rearrangements of MXI1. These results suggest that MXI1 is unlikely to play a role in human pancreatic adenocarcinoma tumorigenesis.
Similar articles
- The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA, Serth J, Bokemeyer C, Schwede J, Herrmann R, Machtens S, Grünewald V, Höfner K, Jonas U. Kuczyk MA, et al. Oncol Rep. 1998 Jan-Feb;5(1):213-6. Oncol Rep. 1998. PMID: 9458379 - Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines.
Wang DY, Xiang YY, Li XJ, Hashimoto M, Tanaka M, Sugimura H. Wang DY, et al. Pathol Int. 2000 May;50(5):373-83. doi: 10.1046/j.1440-1827.2000.01057.x. Pathol Int. 2000. PMID: 10849326 - Mutation of the MXI1 gene in prostate cancer.
Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Eagle LR, et al. Nat Genet. 1995 Mar;9(3):249-55. doi: 10.1038/ng0395-249. Nat Genet. 1995. PMID: 7773287 - Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N, DePinho RA. Schreiber-Agus N, et al. Bioessays. 1998 Oct;20(10):808-18. doi: 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U. Bioessays. 1998. PMID: 9819568 Review. - Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.
Foley KP, Eisenman RN. Foley KP, et al. Biochim Biophys Acta. 1999 May 31;1423(3):M37-47. doi: 10.1016/s0304-419x(99)00012-8. Biochim Biophys Acta. 1999. PMID: 10382539 Review.
Cited by
- Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D, McFerrin L, Carroll PA, Eisenman RN. Diolaiti D, et al. Biochim Biophys Acta. 2015 May;1849(5):484-500. doi: 10.1016/j.bbagrm.2014.05.016. Epub 2014 May 22. Biochim Biophys Acta. 2015. PMID: 24857747 Free PMC article. Review. - An overview of MYC and its interactome.
Conacci-Sorrell M, McFerrin L, Eisenman RN. Conacci-Sorrell M, et al. Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a014357. doi: 10.1101/cshperspect.a014357. Cold Spring Harb Perspect Med. 2014. PMID: 24384812 Free PMC article. Review. - Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.
Boult JK, Tanière P, Hallissey MT, Campbell MJ, Tselepis C. Boult JK, et al. Br J Cancer. 2008 Jun 17;98(12):1985-92. doi: 10.1038/sj.bjc.6604398. Epub 2008 May 20. Br J Cancer. 2008. PMID: 18493233 Free PMC article. - The Max network gone mad.
Baudino TA, Cleveland JL. Baudino TA, et al. Mol Cell Biol. 2001 Feb;21(3):691-702. doi: 10.1128/MCB.21.3.691-702.2001. Mol Cell Biol. 2001. PMID: 11154257 Free PMC article. Review. No abstract available. - c-Myc target genes involved in cell growth, apoptosis, and metabolism.
Dang CV. Dang CV. Mol Cell Biol. 1999 Jan;19(1):1-11. doi: 10.1128/MCB.19.1.1. Mol Cell Biol. 1999. PMID: 9858526 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials